'Null method' determination of drug biophase concentration.
PK/PD modeling is enhanced by improvements in the accuracy of its metrics. For PK/PD modeling of drugs and biologics that interact with enzymes or receptors, the equilibrium constant of the interaction can provide critical insight. Methodologies such as radioliogand binding and isolated tissue preparations can provide estimates of the equilibrium constants (as the dissociation constant, K value) for drugs and endogenous ligands that interact with specific enzymes and receptors. However, an impediment to further precision for PK/PD modeling is that it remains a problem to convert the concentration of drug in bulk solution (A) into an estimate of receptor occupation, since A is not necessarily the concentration (C) of drug in the biophase that yields fractional binding from the law of mass action, viz., C/(C + K). In most experimental studies A is much larger than K, so the use of administered instead of biophase concentration gives fractional occupancies very close to unity. We here provide a simple way to obtain an estimate of the factor that converts the total drug concentration into the biophase concentration in isolated tissue preparation. Our approach is an extension of the now classic 'null method' introduced and applied by Furchgott to determination of drug-receptor dissociation constants.
Department of Pharmacology & Center for Substance Abuse Research, Temple University School of Medicine, Philadelphia, Pennsylvania, 19140, USA. tallarid@temple.edu
Ronald J
RJ
Tallarida
Neil
N
Lamarre
Robert B
RB
Raffa
D000818:Animals; D001011:Aorta / Q000187:drug effects; D008297:Male; D008954:Models, Biological; D009638:Norepinephrine / Q000493:pharmacokinetics* / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014662:Vasoconstrictor Agents / Q000493:pharmacokinetics* / Q000494:pharmacology*
D014662:Vasoconstrictor Agents; D009638:Norepinephrine